학술논문
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
Document Type
article
Source
Dermatology and Therapy, Vol 14, Iss 1, Pp 183-185 (2024)
Subject
Language
English
ISSN
2193-8210
2190-9172
2190-9172